Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study.

Arielle MendelHassan BehlouliCristiano Soares de MouraÉvelyne VinetJeffrey R CurtisSasha Bernatsky

Published in: Arthritis research & therapy (2023)

TMP-SMX was dispensed to a minority of RTX-treated GPA patients, more often to those on glucocorticoids and with recent hospitalization. Further research is needed to determine the optimal use and duration of TMP-SMX prophylaxis following RTX in AAV.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
diffuse large b cell lymphoma
gene therapy
chronic lymphocytic leukemia